These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2903927

  • 1. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis.
    Skosey JL.
    J Rheumatol Suppl; 1988 Sep; 16():5-8. PubMed ID: 2903927
    [Abstract] [Full Text] [Related]

  • 2. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R, European Leflunomide Study Group.
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [Abstract] [Full Text] [Related]

  • 3. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME, Reda D, Henderson W, Giobbie-Hurder A, Williams D, Diani A, Docsa S.
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [Abstract] [Full Text] [Related]

  • 4. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 5. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P.
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ, Teng JL, Bao CD, Han XH, Sun LY, Xu JH, Li XF, Wu HX.
    Chin Med J (Engl); 2008 Apr 05; 121(7):615-9. PubMed ID: 18466681
    [Abstract] [Full Text] [Related]

  • 7. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D, Vischer TL.
    J Rheumatol; 1989 Jan 05; 16(1):19-23. PubMed ID: 2654391
    [Abstract] [Full Text] [Related]

  • 8. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A, Pedone V, Lamanna G, Cervini C.
    Clin Ter; 1997 Jan 05; 148(1-2):7-13. PubMed ID: 9377840
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ.
    J Rheumatol Suppl; 1988 Sep 05; 16():9-13. PubMed ID: 2903928
    [Abstract] [Full Text] [Related]

  • 10. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM, Sitar DS, Hunter T.
    J Rheumatol; 1990 Jun 05; 17(6):764-70. PubMed ID: 1974926
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sulfasalazine in rheumatoid arthritis].
    Segal R, Caspi D, Sukenik S, Horowitz I, Rubinov A, Fluser D, Scharf Y, Shapira D, Weinberger A, Gedz D.
    Harefuah; 1991 May 15; 120(10):577-81. PubMed ID: 1682225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.
    Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S.
    J Rheumatol; 2004 Feb 15; 31(2):243-51. PubMed ID: 14760792
    [Abstract] [Full Text] [Related]

  • 19. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis? The Multicenter Salsalate/Aspirin Comparison Study Group.
    J Rheumatol; 1989 Mar 15; 16(3):321-7. PubMed ID: 2657048
    [Abstract] [Full Text] [Related]

  • 20. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
    Weisman MH.
    Clin Ther; 1986 Mar 15; 8(4):427-38. PubMed ID: 3524843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.